AZN.UK

11,376

+1.61%↑

HLN.UK

395

+2.12%↑

INDV

736

-1.27%↓

AZN.UK

11,376

+1.61%↑

HLN.UK

395

+2.12%↑

INDV

736

-1.27%↓

AZN.UK

11,376

+1.61%↑

HLN.UK

395

+2.12%↑

INDV

736

-1.27%↓

AZN.UK

11,376

+1.61%↑

HLN.UK

395

+2.12%↑

INDV

736

-1.27%↓

AZN.UK

11,376

+1.61%↑

HLN.UK

395

+2.12%↑

INDV

736

-1.27%↓

Search

GlaxoSmithKline PLC

Gesloten

SectorGezondheidszorg

1,460 2.13

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1429

Max

1485.5

Belangrijke statistieken

By Trading Economics

Inkomsten

559M

501M

Verkoop

105M

8.1B

K/W

Sectorgemiddelde

23.581

63.778

EPS

0.232

Dividendrendement

4.3

Winstmarge

6.172

Werknemers

68,629

EBITDA

-52M

1.1B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+11.15% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

4.30%

2.39%

Volgende Winsten

30 apr 2025

Volgende dividenddatum

10 apr 2025

Volgende Ex Dividend datum

15 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-586M

59B

Vorige openingsprijs

1457.87

Vorige sluitingsprijs

1460

Nieuwssentiment

By Acuity

38%

62%

139 / 386 Rangschikking in Healthcare

GlaxoSmithKline PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 feb 2025, 11:32 UTC

Winsten

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook -- 2nd Update

5 feb 2025, 08:56 UTC

Winsten

Correction to GSK Article

5 feb 2025, 08:24 UTC

Winsten

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After Beating Market Views -- Update

5 feb 2025, 07:43 UTC

Winsten

GSK Expects Further Profit Growth After Beating Market Views

13 jan 2025, 07:14 UTC

Acquisities, Fusies, Overnames

GSK to Buy U.S. Rare Tumor Specialist IDRx for Up to $1.15 Billion

2 apr 2025, 09:27 UTC

Populaire aandelen

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

26 mrt 2025, 22:29 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mrt 2025, 19:19 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mrt 2025, 17:39 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

19 mrt 2025, 14:50 UTC

Top Nieuws

HIV Drug Makers Get Spooked by Trump Cuts, but Impact Looks Manageable -- Heard on the Street -- WSJ

17 mrt 2025, 09:00 UTC

Top Nieuws

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

24 feb 2025, 07:05 UTC

Acquisities, Fusies, Overnames

GSK Completes Acquisition of IDRx

14 feb 2025, 11:38 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:30 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb 2025, 15:33 UTC

Marktinformatie
Winsten

GSK's Pipeline Has to Prove It Can Counter Concerns Over Vaccine Business -- Market Talk

5 feb 2025, 08:38 UTC

Marktinformatie
Winsten

GSK Needs to Show It Can Navigate Vaccines Challenge -- Market Talk

5 feb 2025, 07:05 UTC

Winsten

GSK PLC Had Seen 2031 Sales Outlook at More Than GBP38B

5 feb 2025, 07:04 UTC

Winsten

GSK PLC Sees 2031 Sales Outlook at More Than GBP40B

5 feb 2025, 07:03 UTC

Winsten

GSK PLC Sees 2025 Adjusted EPS Growth of 6%-8%

5 feb 2025, 07:03 UTC

Winsten

GSK PLC Raises Mid-Term View

5 feb 2025, 07:03 UTC

Winsten

GSK PLC Sees 2025 Adjusted Operating Growth of 6% - 8%

5 feb 2025, 07:02 UTC

Winsten

GSK PLC Sees 2025 Turnover Growth of 3% to 5%

5 feb 2025, 07:02 UTC

Winsten

GSK PLC Issues GBP2B Buyback

5 feb 2025, 07:01 UTC

Winsten

GSK PLC Declares 4Q Dividend of 16p

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q Core EPS Consensus Was 20.6p

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q Sales Consensus Was GBP7.83B

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q Pretax Pft GBP563M

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q EPS 10.0p

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q Adj EPS 23.2p

5 feb 2025, 07:00 UTC

Winsten

GSK PLC 4Q Oper Pft GBP696M

Peer Vergelijking

Prijswijziging

GlaxoSmithKline PLC Prognose

Koersdoel

By TipRanks

11.15% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,593.33 GBX  11.15%

Hoogste 2,290 GBX

Laagste 1,450 GBX

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor GlaxoSmithKline PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

12 ratings

2

Buy

8

Hold

2

Sell

Sentiment

By Acuity

139 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.